CMH Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.55M Sell
10,878
-555
-5% -$84.2K 0.23% 69
2026
Q2
$1.79M Buy
11,433
+380
+3% +$57K 0.27% 66
2026
Q1
$1.69M Sell
11,053
-272
-2% -$41.7K 0.29% 68

Other funds holding NVS

CMH Wealth Management's NVS Position: Q3 2026 in Review

CMH Wealth Management reduced its Novartis (NVS) stake by 4.9% in Q3 2026, selling an estimated $84.2K and leaving 10,878 shares worth $1.55M. The position accounts for 0.23% of the portfolio, ranked #69.

CMH Wealth Management first reported a position in NVS in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.79M in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • CMH Wealth Management held 10,878 shares of Novartis worth $1.55M as of Q3 2026.
  • CMH Wealth Management sold 555 Novartis shares in Q3 2026, an estimated $84.2K.
  • Novartis made up 0.23% of CMH Wealth Management's portfolio in Q3 2026, its #69 holding.
  • CMH Wealth Management first reported a position in Novartis in Q1 2026 and has held it in 3 quarters since.
  • CMH Wealth Management's Novartis position peaked at $1.79M in Q2 2026.
  • 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on CMH Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.